ISPOR - Growing Rates of Obesity

vos-headline-type-email-header-062620

Featured

Measuring the Promise of Obesity Drugs

ISSUE HIGHLIGHTS

From the Editor

Weighing in on the Obesity Epidemic

From the President

ISPOR, HEOR, and the Study and Treatment of Obesity

ISPOR News

ISPOR's 2024-2025 Top 10 HEOR Trends

HEOR Articles

Patient Involvement in Regulatory and Health Technology Assessment Processes: A Call for Enhanced Alignment

VOL. 10, NO. 1

January/February 2024

DOWNLOAD ISSUE

COLUMNS

vos_heorarticles_100x100

HEOR Articles

Solving the Real-World Evidence Challenge for US Payers: A Call to Action for Pharma

vos_heorarticles_100x100

HEOR Articles

How Can Manufacturers of Orphan Drugs for Rare Diseases Optimize Clinical Trial Design for Market Access Across the United States, France, Germany, and the United Kingdom?

vos_heornews_100x100

HEOR News

vos_researchroundup_100x100

Research Roundup

Research Roundup

vos_bythenumbers_100x100

By the Numbers

By the Numbers: Growing Rates of Obesity

vos_conferences_100x100

ISPOR Conferences

ISPOR Conferences and Events

Latest News

Global Expert Panel Releases Good Practices Guidance for Developing or Updating Health Technology Assessment Guidelines

Jan 14, 2025

Rethinking Value Assessment for Orphan Drugs

Dec 18, 2024

ISPOR Launches “HEOR Explained” Microsite

Dec 10, 2024

ISPOR Releases Emerging Good Practices Guidance on Quantifying Specialized Knowledge in Healthcare

Nov 6, 2024

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now